Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ghanekar

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
BMC Immunology|July 20, 2005
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOTHolden T Maecker, James Moon, Sonny Bhatia, et al.
Annals of Surgical Oncology|December 5, 2014
Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American SeriesG Sapisochin, N Goldaracena, S Astete, et al.
Annals of Medicine and Surgery (2012)|May 31, 2022
Long-term outcomes of ablation, liver resection, and liver transplant as first-line treatment for solitary HCC of 3 cm or less using an intention-to-treat analysis: A retrospective cohort studyT Ivanics, L Rajendran, P A Abreu, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
BMC Immunology|July 20, 2005
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOTHolden T Maecker, James Moon, Sonny Bhatia, et al.
Annals of Surgical Oncology|December 5, 2014
Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American SeriesG Sapisochin, N Goldaracena, S Astete, et al.
Annals of Medicine and Surgery (2012)|May 31, 2022
Long-term outcomes of ablation, liver resection, and liver transplant as first-line treatment for solitary HCC of 3 cm or less using an intention-to-treat analysis: A retrospective cohort studyT Ivanics, L Rajendran, P A Abreu, et al.
Pageof 5